Medtronic plc Insider Trading Activity

Accepted by SEC EDGAR 08/04/2025 - 04:16 PM EDT Learn about SEC filing dates

Insider Trade Summary

10,457 shares exercised/converted

Exercise 4 txns

Insider KIIL HARRY SKIP

Role EVP & President Cardiovascular

Type	Security	Shares	Price	Value
Exercise	Performance Share Unit	10,457	$0.00	$0.00
Exercise	Ordinary Shares	10,457	$0.00	$0.00
Exercise Price or Tax Liability	Ordinary Shares	4,659	$89.34	$416K
Exercise Price or Tax Liability	Ordinary Shares	2,896	$89.34	$259K

Holdings After Transaction: Performance Share Unit — 0 contracts (Direct); Ordinary Shares — 44,220 shares (Direct)

Footnotes (5)

1. F1. Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 1, 2022 and earned dividend equivalents.
2. F2. Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 1, 2025.
3. F3. Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.
4. F4. Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
5. F5. The performance share units vested on August 1, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KIIL HARRY SKIP

(Last) (First) (Middle)

710 MEDTRONIC PARKWAY

(Street)

MINNEAPOLIS MN 55432

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & President Cardiovascular

3. Date of Earliest Transaction (Month/Day/Year)
08/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/01/2025		M		10,457(1)	A	$0	51,775	D
Ordinary Shares	08/01/2025		F		4,659(2)	D	$89.34	47,116	D
Ordinary Shares	08/01/2025		F		2,896(3)	D	$89.34	44,220	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Share Unit	(4)	08/01/2025		M			10,457	(5)	(5)	Ordinary Shares	10,457	$0	0	D

Explanation of Responses:

1. Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 1, 2022 and earned dividend equivalents.

2. Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 1, 2025.

3. Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.

4. Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

5. The performance share units vested on August 1, 2025.

Remarks:

	/s/ Patricia Walesiewicz, attorney-in-fact	08/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.